Suppr超能文献

The importance of hypertension as a risk factor for severe illness and mortality in COVID-19.

作者信息

Cook T M

机构信息

Royal United Hospitals Bath NHS Foundation Trust, Bath, UK.

出版信息

Anaesthesia. 2020 Jul;75(7):976-977. doi: 10.1111/anae.15103. Epub 2020 May 9.

Abstract
摘要

相似文献

1
The importance of hypertension as a risk factor for severe illness and mortality in COVID-19.
Anaesthesia. 2020 Jul;75(7):976-977. doi: 10.1111/anae.15103. Epub 2020 May 9.
2
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
Lancet Respir Med. 2020 Apr;8(4):e21. doi: 10.1016/S2213-2600(20)30116-8. Epub 2020 Mar 11.
3
Severity of COVID-19: The importance of being hypertensive.
Monaldi Arch Chest Dis. 2020 May 20;90(2). doi: 10.4081/monaldi.2020.1372.
4
Arterial hypertension and the risk of severity and mortality of COVID-19.
Eur Respir J. 2020 Jun 11;55(6). doi: 10.1183/13993003.01148-2020. Print 2020 Jun.
5
COVID-19: Knowns, Unknowns, and Questions.
mSphere. 2020 Mar 18;5(2):e00203-20. doi: 10.1128/mSphere.00203-20.
7
Comparison of clinical characteristics of coronavirus disease (COVID-19) and severe acute respiratory syndrome (SARS) as experienced in Taiwan.
Travel Med Infect Dis. 2020 Jul-Aug;36:101625. doi: 10.1016/j.tmaid.2020.101625. Epub 2020 Mar 14.
8
Arterial hypertension and risk of death in patients with COVID-19 infection: Systematic review and meta-analysis.
J Infect. 2020 Jul;81(1):e84-e86. doi: 10.1016/j.jinf.2020.03.059. Epub 2020 Apr 11.
9
Identification and validation of predictive factors for progression to severe COVID-19 pneumonia by proteomics.
Signal Transduct Target Ther. 2020 Oct 3;5(1):217. doi: 10.1038/s41392-020-00333-1.
10
Coronavirus Disease 2019 (COVID-19): A critical care perspective beyond China.
Anaesth Crit Care Pain Med. 2020 Apr;39(2):167-169. doi: 10.1016/j.accpm.2020.03.001. Epub 2020 Mar 3.

引用本文的文献

2
A Comprehensive Review of Natural Flavonoids with Anti-SARS-CoV-2 Activity.
Molecules. 2023 Mar 17;28(6):2735. doi: 10.3390/molecules28062735.
4
A Calculator for COVID-19 Severity Prediction Based on Patient Risk Factors and Number of Vaccines Received.
Microorganisms. 2022 Jun 16;10(6):1238. doi: 10.3390/microorganisms10061238.
6
Factors associated with the risk perception of COVID-19 infection and severe illness: A cross-sectional study in Japan.
SSM Popul Health. 2022 Jun;18:101105. doi: 10.1016/j.ssmph.2022.101105. Epub 2022 Apr 26.
7
Seroprevalence of COVID-19 in Riyadh city during the early increase of COVID-19 infections in Saudi Arabia, June 2020.
Saudi J Biol Sci. 2022 Jun;29(6):103282. doi: 10.1016/j.sjbs.2022.103282. Epub 2022 Apr 22.
8
Investigating the interrelatedness of clinical and non-clinical parameters affecting outcomes in COVID-19 patients: a retrospective study.
Pathog Glob Health. 2023 Mar;117(2):212-218. doi: 10.1080/20477724.2022.2064796. Epub 2022 Apr 25.
9
Predicting COVID-19 severity using major risk factors and received vaccines.
medRxiv. 2022 Jan 3:2021.12.31.21268575. doi: 10.1101/2021.12.31.21268575.
10
Covid-19: pharmacotherapeutic insights on various curative approaches in terms of vulnerability, comorbidities, and vaccination.
Inflammopharmacology. 2022 Feb;30(1):1-21. doi: 10.1007/s10787-021-00904-w. Epub 2022 Jan 3.

本文引用的文献

2
Clinical Course and Outcomes of 344 Intensive Care Patients with COVID-19.
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1430-1434. doi: 10.1164/rccm.202003-0736LE.
4
Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis.
Int J Infect Dis. 2020 May;94:91-95. doi: 10.1016/j.ijid.2020.03.017. Epub 2020 Mar 12.
5
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
6
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
Lancet Respir Med. 2020 Apr;8(4):e21. doi: 10.1016/S2213-2600(20)30116-8. Epub 2020 Mar 11.
7
Clinical Characteristics of Coronavirus Disease 2019 in China.
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
10
Status of Hypertension in China: Results From the China Hypertension Survey, 2012-2015.
Circulation. 2018 May 29;137(22):2344-2356. doi: 10.1161/CIRCULATIONAHA.117.032380. Epub 2018 Feb 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验